Predictions
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.91
11.11.23
11.11.23
€2.00
11.11.24
11.11.24
12.13%
25.11.23
25.11.23
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
22.11.22
22.11.22
-
22.11.23
22.11.23
-66.14%
23.11.23
23.11.23
Could be worthwhile Investment >10% per year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.47
30.10.23
30.10.23
-
30.10.24
30.10.24
-27.89%
10.11.23
10.11.23
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.68
29.10.23
29.10.23
€2.80
30.09.25
30.09.25
-
30.10.23
30.10.23
Could be very worthwhile Investment >20% year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.28
01.10.23
01.10.23
€2.00
30.09.25
30.09.25
14.84%
29.10.23
29.10.23
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.64
30.09.23
30.09.23
€1.00
30.09.24
30.09.24
-9.76%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Cellectis SA ADR
Start price
Target price
Perf. (%)
€2.32
07.10.22
07.10.22
€5.00
07.10.23
07.10.23
-43.97%
08.10.23
08.10.23
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€5.11
16.09.23
16.09.23
€2.00
16.09.24
16.09.24
-14.09%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€4.58
13.04.23
13.04.23
-
13.04.26
13.04.26
-14.85%
26.09.23
26.09.23
Risky Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.14
09.09.23
09.09.23
€3.00
09.09.24
09.09.24
-18.69%
16.09.23
16.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.67
02.09.23
02.09.23
€17.00
02.09.24
02.09.24
-5.50%
16.09.23
16.09.23
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€6.87
13.09.23
13.09.23
-
13.09.24
13.09.24
-27.22%
15.09.23
15.09.23
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.97
03.09.23
03.09.23
-
03.09.24
03.09.24
-21.32%
13.09.23
13.09.23
Risky Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.40
11.09.23
11.09.23
-
11.09.24
11.09.24
-22.50%
12.09.23
12.09.23
Probably not worthwhile Investment